CBD_SBIR_25.4_R12.pdf

PDF 467 KB Posted

Attached to
OPEN TOPIC - Tactical CB Visualization
Solicitation number
CBD254-009
Issued by

About this file

This is a Proposal Submission Instructions document for the Chemical and Biological Defense Program (CBDP) FY25.4 Small Business Innovation Research (SBIR) Program, Release 12.

The document provides comprehensive guidance for small business concerns (SBCs) submitting proposals to eight approved research topics addressing chemical and biological defense capabilities. All proposals must be submitted through the Defense SBIR/STTR Innovation Portal (DSIP) at https://www.dodsbirsttr.mil. Phase I proposals have a maximum funding cap of $209,575.00 for up to six months of performance. Direct to Phase II (DP2) proposals are available for eligible topics and have a base amount not to exceed $698,582.50 with a 12-month period of performance plus a 12-month option, totaling no more than $1,397,165.00. Phase II awards are typically structured as cost-plus fixed fee contracts, though firm fixed price contracts are possible at the Contracting Officer's discretion. Proposals must comply with all requirements in the DoD Program SBIR BAA, including completion of Fraud, Waste and Abuse training, disclosure of foreign nationals or dual citizens, and submission of foreign affiliation disclosures in Volume 7 of DSIP. The technical volume for Phase I is limited to 20 pages with 10-point minimum font; DP2 proposals have a 25-page limit split between feasibility documentation (5 pages) and technical proposal (20 pages). Research involving human or animal subjects is prohibited in Phase I but may be proposed for Phase II, requiring DoD-level approvals from the Office of Human Research Oversight (OHRO) or Animal Care and Use Review Office (ACURO). The eight topics cover detection technologies, advanced manufacturing, visualization systems, diagnostics, and medical countermeasures, with two designated as open topics allowing proposer-defined approaches. Offerors will be notified of selection or non-selection within 90 days, with technical debriefs available upon written request within five business days of notification.

View the file

Other files

File Type Posted
CBD254-009.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

CBD – 1

CHEMICAL AND BIOLOGICAL DEFENSE PROGRAM

25.4 Small Business Innovation Research (SBIR)

Release 12

Proposal Submission Instructions

The approved FY25.4 topics for Release 12 are included in the Chemical and Biological Defense Program

(CBDP) Small Business Innovation Research (SBIR) Program as provided in this document. Offerors responding to this Announcement must follow all general instructions included in the Department of

Defense (DoD) Program SBIRBAA, as well as the CBD SBIR Topic Instructions below, detailing specific CBD SBIR program requirements.

Proposers are encouraged to thoroughly review the DoD Program Broad Agency Announcement

(BAA), as well as register for the DoD SBIR/STTR Innovation Portal (DSIP) Listserv to remain apprised of important programmatic and contractual changes.

• The DoD Program BAA: https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations Be sure to select the tab for the appropriate BAA cycle.

• Register for the DSIP Listserv at: https://www.dodsbirsttr.mil/

Please read the entire DoD Announcement and these CBD SBIR instructions carefully prior to submitting your proposal. Important programmatic changes have been incorporated as required by the SBIR and

STTR Extension Act of 2022 (Pub. L. 117-183). Also, go to https://www.sbir.gov/about/policies to read the SBIR/STTR Policy Directive issued by the U. S. Small Business Administration (SBA).

INTRODUCTION

In response to Congressional interest in the readiness and effectiveness of U.S. Nuclear, Biological and

Chemical (NBC) warfare defenses, Title XVII of the National Defense Authorization Act for Fiscal Year

1994 (Public Law 103-160) requires the Department of Defense (DoD) to consolidate management and oversight of the Chemical and Biological Defense Program (CBDP) into a single office – Office of the

Assistant Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. The Joint

Science and Technology Office for Chemical and Biological Defense (JSTO CBD), located at the

Defense Threat Reduction Agency (DTRA), provides the management for the Science and Technology component of the CBDP. Technologies developed under the Small Business Innovation Research (SBIR)

Program have the potential to transition to the Joint Program Executive Office for Chemical Biological

Radiological and Nuclear Defense (JPEO CBRND) if the appropriate level of technology maturity is demonstrated. The JSTO CBD Science & Technology programs and initiatives improve defensive capabilities against Chemical and Biological Weapons of Mass Destruction. The SBIR portion of the

CBD Program is managed by JSTO CBD.

The mission of the CBDP is to ensure that the U.S. Military has the capability to operate effectively and decisively in the face of chemical or biological warfare threats at home or abroad. Numerous factors continually influence the program and its technology development priorities. Improved defensive capabilities are essential to mitigate the overall impact of chemical and biological threats. The U.S.

military requires the finest state-of-the-art equipment and instrumentation available to permit our Joint

Force to ‘detect to warn’ and avoid contamination, if possible – and to be able to sustain operations in a potentially contaminated environment. Further information is available at the Office of the Assistant

Secretary of Defense for Nuclear Deterrence, Chemical, and Biological Defense Policy and Programs homepage at https://www.acq.osd.mil/ncbdp/cbd/.

https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations https://www.sbir.gov/about/policies https://www.acq.osd.mil/ncbdp/cbd/

CBD – 2

The overall objective of the CBD SBIR Program is to improve the transition or transfer of innovative

CBD technologies to the end user – the Joint Force – in addition to commercializing technologies within the private sector for mutual benefit. The CBD SBIR Program targets technology efforts that maximize a strong defensive posture in a biological or chemical environment using passive and active means as deterrents. These technologies include chemical and biological detection for both point and stand-off capabilities; individual and collective protection; hazard mitigation (decontamination); medical pre-treatments (e.g., vaccine development and delivery); medical therapeutics (chemical and biological countermeasures); medical diagnostics; information systems technology to include but not limited to modeling and simulation (e.g., meteorological dispersion), disease surveillance, data fusion, and health & human effects to include wearable technologies.

All proposals submitted to the CBD SBIR program must comply to the terms of this Announcement.

CBD SBIR reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality, as determined by the Technical Evaluation Team and the CBD SBIR program office will be funded. CBD SBIR reserves the right to withdraw from negotiations at any time prior to contract award. The Government may withdraw from negotiations at any time for any reason to include matters of national security (foreign persons, foreign influence or ownership, or other related issues).

Use of Foreign Nationals (also known as Foreign Persons), Green Card Holders, and Dual Citizens

See the “Foreign Nationals” section of the DoD SBIR Program Announcement for the definition of a

Foreign National (also known as Foreign Persons).

It is the responsibility of ALL offerors proposing who use foreign nationals, green-card holders, or dual citizens, to disclose this information regardless of whether the topic is subject to export control restrictions. Offerors MUST identify any foreign nationals or individuals holding dual citizenship expected to be involved on this project as a direct employee, subcontractor, or consultant.

NOTE: For these individuals, specify their country of origin, the type of visa or work permit under which they are performing and an explanation of their anticipated level of involvement on the project. You may be asked to provide additional information during contract negotiations to verify the foreign citizen’s eligibility to participate on a SBIR contract. Supplemental information provided in response to this paragraph will be protected in accordance with the Privacy Act (5 U.S.C. 552a), if applicable, and the

Freedom of Information Act (5 U.S.C. 552(b)(6)).

Proposers responding to this BAA must follow all general instructions provided in the Department of

Defense (DoD) SBIR Program BAA, paying special attention to the requirements under the SBIR and

STTR Extension Act of 2022 (Pub. L. 117-183). The Chemical and Biological Defense SBIR Program requirements are provided in the instructions below.

Specific questions pertaining to the administration of the CBD SBIR Program and these proposal preparation instructions should be directed to the CBD SBIR/STTR Program Management Office (CBD

SBIR PMO) at dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil.

CBD SBIR instructions are for research topics accepting Phase I or Direct to Phase II proposals. Separate guidance will be issued requesting Phase II proposals, and unsolicited proposals will not be accepted. All proposing SBCs that receive a Phase I award from this BAA will be eligible to participate in Phase II competitions. CBD SBIR program office will notify Phase I awardees of the Phase II proposal submission requirements.

CBD SBIR PMO is not obligated to make any awards under Phase I and Phase II and is not responsible mailto:dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil

CBD – 3

for any monies the proposing small business concern (SBC) spends before any award issuance. Proposals must conform to this announcement’s terms. CBD SBIR program office is under no obligation to fund any proposal or any specific number of proposals under each topic. CBD SBIR PMO also may choose to fund several or none of the proposed approaches to the same topic.

PHASE I PROPOSAL GUIDELINES

The Defense SBIR/STTR Innovation Portal (DSIP) is the official portal for DoD SBIR/STTR proposal submission. Firms are required to submit proposals via DSIP; proposals submitted by any other means will be disregarded. Detailed instructions regarding registration and proposal submission are provided in the DoD SBIR Program BAA.

a. Proposal Coversheet (Volume 1)

The proposal coversheet must follow the instructions and requirements provided in the DoD SBIR 25.4

Program BAA. The offeror shall certify to the best of their knowledge eligibility information under the

SBIR Program is accurate, complete, and current as of the date submitted.

b. Technical Volume (Volume 2)

The technical volume is not to exceed 20-pages and must follow the formatting requirements provided in the DoD SBIR Program BAA. No other information included in the other proposal volumes will count against the Proposal Technical Volume page limit. Pages provided exceeding this length will not be considered for review. The proposal must not contain any font type smaller than 10-point font size

(except as a legend on reduced drawings, but not in the tables).

The maximum dollar amount for a Phase I proof-of-concept/feasibility study is $209,575.00 for a period of performance (PoP) of up to six (6) months. The CBD SBIR Program will not accept proposals exceeding this amount for the Phase I effort.

The entire proposal submission must be submitted through the Defense SBIR/STTR Innovation

Portal (DSIP) located at: https://www.dodsbirsttr.mil. Any questions pertaining to the DoD

SBIR/STTR submission process and system should be directed to DSIP Support:

DoDSBIRSupport@reisystems.com

Selection of Phase I proposals will be based upon the three (3) evaluation criteria as mentioned in the

DoD BAA. The CBD SBIR Program reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality deemed by the Technical Evaluation Team will be funded. All SBIR contract awards, both Phase I and Phase II, are subject to availability of funding.

The brief Period of Performance available for a Phase I project precludes plans that include research involving human or animal subjects as all associated DoD requirements and the necessary approvals must be strictly adhered to and require considerable coordination and significant time for final protocol approvals. See “Research Involving Human Subjects, Biospecimens, and/or Animal Use,” below for further information.

Proposals not conforming to the terms of this Announcement, and any unsolicited proposals, will not be considered. All awards are subject to the availability of funding and successful completion of contract negotiations. The Chemical and Biological Defense Program is not responsible for any funds expended by the proposer prior to contract award.

c. Cost Volume (Volume 3)

The Cost Volume must follow all instructions and requirements provided in the DoD SBIR Program https://www.dodsbirsttr.mil/ mailto:DoDSBIRSupport@reisystems.com

CBD – 4

BAA. The Phase I Base amount must not exceed $209,575.00. Total Base cost for Phase I must be clearly identified on the Proposal Cover Sheet (Volume 1) and in Volume 3.

Please review the updated Percentage of Work (POW) calculation details included in the DoD Program

BAA

d. Company Commercialization Report (CCR) (Volume 4)

Completion of the CCR is required and included in Volume 4 of the DSIP portal. Please refer to the DoD

SBIR Program BAA for full details on this requirement. Information contained in the CCR will not be considered by the CBDP in the proposal evaluations.

e. Supporting Documents (Volume 5)

Volume 5 is provided for proposing SBCs to submit additional documentation to support the Coversheet

(Volume 1), Technical Volume (Volume 2), and the Cost Volume (Volume 3). Please refer to the DoD

Program BAA for more information. Offerors are welcome to provide Supporting Documents in this section, however these documents will not be considered by the Chemical and Biological Defense

Program in the proposal evaluations.

f. Fraud, Waste and Abuse (Volume 6)

All offerors must complete the Fraud, Waste, and Abuse training through the DSIP portal

(https://www.dodsbirsttr.mil). Please follow the guidance provided via DSIP to complete the required training prior to proposal submission.

To Report Fraud, Waste, or Abuse, please contact:

DoD Inspector General (IG) Fraud, Waste & Abuse

Hotline: (800) 424-9098 hotline@dodig.mil

Additional information on Fraud, Waste and Abuse may be found in the DoD Announcement.

g. . Disclosures of Foreign Affiliations or Relationships to Foreign Countries (Volume 7)

Small business concerns must complete the Disclosures of Foreign Affiliations or Relationships to

Foreign Countries webform in Volume 7 of the DSIP proposal submission. Please be aware that the

Disclosures of Foreign Affiliations or Relationships to Foreign Countries WILL NOT be accepted as a

PDF Supporting Document in Volume 5 of the DSIP proposal submission. Do not upload any previous versions of this form to Volume 5. For additional details, please refer to the DoD Program BAA.

DIRECT TO PHASE II PROPOSAL GUIDELINES

The Chemical and Biological Defense SBIR Program is participating in Direct to Phase II (DP2), only when specifically noted in the topic documentation. Not all topics include a Direct to Phase II option.

Implementing the authority granted by 15 U.S.C. §638 (cc), as amended by the SBIR AND STTR

EXTENSION ACT OF 2022, the CBD will be conducting ‘Direct to Phase II’ contract awards for eligible

SBIR topics. Each eligible topic requires documentation to determine whether the feasibility requirement described in the Phase I section of the topic has been met.

Each eligible topic requires proposing SBCs provide documentation to demonstrate feasibility described in the Phase I section of the topic has been met. Feasibility documentation cannot be based upon or logically extend from any prior or ongoing federally funded SBIR or STTR work. The proposing SBC and/or the principal investigator must have substantially performed the work submitted in the feasibility documentation. If technology in the feasibility documentation is subject to intellectual property (IP), the mailto:hotline@dodig.mil

CBD – 5

proposing SBC must demonstrate ownership or licensure of the IP associated with such technology prior to proposal submission to enable it and its subcontractors to legally carry out the proposed work. If the proposing SBC fails to demonstrate technical merit and feasibility equivalent to the Phase I as described in the associated topic, the related Phase II proposal will not be accepted or evaluated, in accordance to the Direct to Phase II instructions.

a. Proposal Cover Sheet (Volume 1)

See the Phase I Proposal Instruction section above.

b. Technical Volume (Volume 2)

The following technical volume content instructions supersede those stated in the Phase I Proposal

Instruction section above. Offerors may submit DP2 proposals only if allowed pursuant to the topic posting. The following technical volume formatting requirements supplement those found within in the

DoD SBIR 25.4 Program BAA, including any revisions/amendments.

Guidance for DP2 Format:

Length: For DP2 proposals, the Technical Volume is broken into two (2) sections: Feasibility

Documentation, which is subject to a page limitation of five (5) pages; and a Technical Proposal, which is subject to a page limitation of twenty (20) pages. The Technical Volume, therefore, shall not exceed twenty-five (25) pages and shall follow the formatting requirements provided in the

DoD SBIR 25.4 Program BAA. It is the proposing SBC’s responsibility to verify that the

Technical Volume does not exceed the page limit after upload to DSIP. Any proposals exceeding the page count limit will be deemed unresponsive.

For DP2 proposals, the technical volume shall include two (2) sections, Feasibility Documentation and a

Technical Proposal.

Volume 2A, Feasibility Documentation

Feasibility documentation shall not exceed five (5) pages in length.

Proposers interested in submitting a DP2 proposal must respond to this topic with documentation substantiating the scientific ,technical merit and feasibility described in the Phase I section of this topic has been met and describe any potential commercial application. Documentation shall include all relevant information including but not limited to: technical reports (summary and citation), test data, prototype designs/models, and performance goals/results. If references exist, the offeror shall include a reference list or works cited list as the last page of the feasibility documentation. This will count towards the total page limit.

Work submitted within the feasibility documentation must have been substantially performed by the firm. Feasibility documentation cannot be based upon any prior or ongoing federally funded

SBIR or STTR work and MUST NOT logically extend from any prior or ongoing federally funded SBIR or STTR work. It is the offeror’s responsibility to ensure compliance. Should the

Government find a violation before contract award, the proposal will be rejected. Should the

Government find a violation after contract award, the Government has the right to terminate the contract.

If technology in the feasibility documentation is subject to Intellectual Property (IP), the proposing small business concern must either own the IP or must have obtained license rights to such technology prior to proposal submission, to enable it and its subcontractors to legally carry out the proposed work.

CBD – 6

If the SBC fails to demonstrate the appropriate technical merit and feasibility equivalent to the

Phase I portion of the associated topic and fails to demonstrate that the work submitted in the feasibility documentation was substantially performed by the proposer and/or the PI the related

Phase II proposal, then the effort will be deemed unresponsive.

Volume 2B, Technical Proposal

The Technical Proposal shall not exceed twenty (20) pages in length and shall contain two key parts: (1) technical approach and (2) team qualifications.

Volume 2B, Part 1 – Technical Approach. The technical approach section shall explain, in detail, how the offeror is going to solve the specific technical problem or opportunity addressed in the topic. The offeror shall include a statement of work with explicit, detailed descriptions and key elements of the technical approach (including subcontractors’ efforts), any risks, relevant past work and how success was measured and how it will be measured for this effort. Explain objectives while avoiding technical verbiage. The statement of work shall indicate what tasks are planned, how and where the work will be conducted, a schedule of major events and meetings, and the final product(s) to be delivered (reference the ‘Contractual Requirements’ section above).

The Phase II effort should attempt to provide proof of concept and prototype development. The methods planned to achieve each objective, or task should be discussed explicitly and in detail and should be a substantial portion of the Technical Volume. Please refer to Additional

Information section in instructions for activities involving Human/Animal and/or Recombinant

DNA.

Volume 2B, Part 2 – Team Qualifications. The team qualifications section shall highlight identify the key personnel working on the project (including information on directly related education and experience), and the resources used to solve the problem.

Identify any foreign citizens or individuals holding dual citizenship expected to be involved on this project as a direct employee, subcontractor, or consultant. For these individuals, please specify their country of origin, the type of visa or work permit under which they are performing and an explanation of their anticipated level of involvement in this effort Note: You may be asked to provide additional information during proposal evaluation and/or contract negotiations in order to verify the foreign citizen’s eligibility to participate on a SBIR contract. Supplemental information provided in response to this paragraph will be protected in accordance with the

Privacy Act (5 U.S.C. 552a), if applicable, and the Freedom of Information Act (5 U.S.C.

552(b)(6)). The Government may withdraw from negotiations at any time for any reason to include matters of national security (foreign persons, foreign influence or ownership, inability to clear the firm or personnel for security clearances, or other related issues).

c. Cost Volume (Volume 3)

The following cost volume content instructions supersede those stated in the Phase I Proposal Instruction section above. For DP2 proposals, the base amount must not exceed $698,582.50 with a period of performance (PoP) of twelve (12) months and will include a twelve (12) month option not to exceed the base amount. Total amount of the base and option year is not to exceed $1,397,165.00. Total cost for

Direct to Phase II must be clearly identified on the Proposal Cover Sheet. A firm fixed price (FFP) or cost-plus fixed fee Phase II Cost Volume must be submitted in detail.

d. Company Commercialization Report (CCR) (Volume 4)

CBD – 7

e. Supporting Documents (Volume 5)

f. Fraud, Waste and Abuse (Volume 6)

g. Disclosures of Foreign Affiliations or Relationships to Foreign Countries (Volume 7)

PHASE II PROPOSAL GUIDELINES

Offerors may only submit a Phase II proposal after receipt of a Phase I award.

Phase II is the demonstration of the technology that was found feasible in Phase I. A Phase II proposal may not be submitted until sufficient Phase I progress can be evaluated and assessed, and the Period of

Performance (PoP) is nearing completion. The CBD Program Office will invite the SBC to submit a

Phase II proposal, no sooner than five (5) months from the date of the Phase I contract award;

submissions instructions will be provided with the invitation.

All Phase II proposal submissions must be submitted on the DSIP portal: https://www.dodsbirsttr.mil.

At the DSIP website, Phase II proposals MUST be submitted to ‘CBD SBIR’ regardless of which DoD contracting office negotiated and awarded the Phase I contract. The CBD SBIR PMO will provide additional instructions regarding the Phase II proposal submission process to include submission dates to the Phase I awardees after the Phase I contract is awarded.

The Phase II proposal must include a concise summary of the Phase I project including the specific technical problem or opportunity addressed in the proposal. The proposal must also include an objective statement, the type of research conducted, findings and/or results of the research, and technical feasibility of the technology. Due to limited funding, the CBD SBIR program reserves the right to limit awards under any topic and only proposals considered to be of superior quality will be funded.

All proposers are required to submit a commercialization plan that describes the SBC’s marketing and manufacturing approach to developing the technology. The Offeror is required to submit a budget for the entire 24-month Phase II Period of Performance. During contract negotiation, the Contracting Officer may require a Cost Volume for a base year and an option year; thus, proposers are advised to be aware of this possibility. These costs must be submitted using the Cost Volume format within the DSIP website.

The total proposed amount should be indicated on the Proposal Cover Sheet as the Proposed Cost. At the

Contracting Officer’s discretion, Phase II projects may be evaluated for technical progress prior to the end of the base year (year one), to decide whether to extend the funding for the option year (year two).

It is recommended that Phase II awardees have a Defense Contract Audit Agency (DCAA) approved accounting system. If you do not have a DCAA approved accounting system, this could delay and/or prevent a Phase II contract award. Visit https://www.dcaa.mil/Customers/Small-Business for more information on DCAA approved accounting systems.

DISCRETIONARY TECHNICAL AND BUSINESS ASSISTANCE (TABA)

Currently, the CBD SBIR Program does not participate in the Technical and Business Assistance (TABA)

Program.

https://www.dcaa.mil/Customers/Small-Business

CBD – 8

EVALUATION AND SELECTION

All proposals will be evaluated in accordance with the evaluation criteria listed in the DoD SBIR Program

BAA.

Offerors will be notified of selection or non-selection at the close of the BAA. Notification will be made within the 90-day window requirement. The CBD SBIR Program office will notify the firm via e-mail to the firm’s Corporate Official (Business Point of Contact) and Principal Investigator, as listed on the

Cover Page of the proposal.

The firm may submit an email request to the CBD SBIR/STTR mailbox (https://dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil) to request a technical debrief. Requests must be received within five (5) business days from the notification of selection or non-selection. The CBD SBIR Program Office will a provide a debriefing statement if request is submitted within three days of non-selection notification. The debriefing statement will only be provided to the Corporate Official and the Principal

Investigator on the Cover Page of the proposal. Requests made by the offeror after 5 business days from the date of notification (selection or non-selection) or for further information will not be provided.

Refer to the DoD SBIR Program BAA for guidance concerning protests.

As further prescribed in FAR 33.106(b), FAR 52.233-3, Protests after Award should be submitted to the

Chemical and Biological Defense (CBD) SBIR/STTR Program Management Office at dtra.belvoir.rd.mbx.jsto-cbd- chem-bio-defense-sbir@mail.mil.

AWARD AND CONTRACT INFORMATION

Contract and award negotiations are handled by each of the CBD SBIR PMO partner contracting organizations. After offerors are notified of selection, the CBD SBIR PMO’s partner Contracting Officer will begin contract negotiations with the firm. All SBIR contract awards, both Phase I and Phase II, are subject to availability of funding and mission priorities.

The CBD SBIR Program is committed to minimizing the funding gap between Phase I and Phase II activities. The CBD SBIR Program typically funds a cost-plus fixed fee Phase II award at the discretion of the Contracting Officer but may award a firm fixed price contract.

ADDITIONAL INFORMATION

RESEARCH INVOLVING HUMAN SUBJECTS, BIOSPECIMENS, AND/OR ANIMAL USE

Any research under a Phase I or Phase II contract involving human subjects, human anatomical substances (e.g., whole blood, cell lines, tissue), and/or animal use must undergo the regulatory review requirements per DoD Instruction 3216.02 and DoD Instruction 3216.01, respectively.

DoD-level review and approval of human and/or animal use are separate from, and in conjunction with the Institutional Review Board (IRB) and/or the Institutional Animal Care and Use Committee (IACUC).

CBD SBIR Projects Requiring Animal Subjects

Refer to the DoD Program BAA for Research Involving Animal Subjects.

Companies should plan carefully for any research involving animal subjects, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of

Concern (DURC)”. The mandatory DoD level review of this research is typically a period of no greater https://dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil https://dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil mailto:dtra.belvoir.rd.mbx.jsto-cbd-mailto:dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil

CBD – 9

than four (4) months.

Projects under CBD SBIR awards involving the use of animal subjects shall not be proposed for any

Phase I effort but may be proposed under the Phase II proposal submission.

Written authorization to begin animal research under the applicable protocol(s) proposed as part of the

CBD SBIR/STTR program will be issued after the contract award in the form of an approval memo. The approval will come from the U.S. Army Medical Research and Development Command (MRDC), Animal Care and Use Review Office (ACURO), and the Research Oversight Board (ROB) of the Defense

Threat Reduction Agency (DTRA). Both offices provide DoD compliance oversight to the CBD SBIR and STTR programs.

NOTE: The offeror is expressly forbidden from using or subcontracting the use of animals in any manner prior to these approvals. Furthermore, modifications to approved protocols require review and approval by the ACURO prior to implementation.

Non-compliance to these terms and conditions may result in withholding of funds and/or the termination of the award. The ACURO and DTRA ROB reviews are separate from, and in addition to the responsible

Institutional Animal Care and Use Committee (IACUC) review(s). Further information may be required if the proposal is successful.

CBD SBIR Projects Requiring Human Subjects, Human Anatomical Substances, and/or Human Data

Refer to the DoD Program BAA for Research Involving Human Subjects and Recombinant DNA

Molecules.

Companies should plan carefully for any research involving human subjects, human data, and/or human biospecimens (e.g., blood, saliva, tissue), to include cadaveric specimens, hereafter referred to as

“research”, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of Concern (DURC)”. The mandatory DoD level review of this research is typically no greater than four (4) months.

Projects under CBD SBIR awards involving the use of human subjects shall not be proposed for any

Phase I Period of Performance but may be proposed during the Phase II proposal submission.

Written authorization to begin the research under the applicable protocol(s) proposed as part of the CBD

SBIR/STTR program will be issued after the contract award in the form of an approval memo from the

Defense Health Agency (DHA) Research & Development-Medical Research and Development Command

(MRDC), Office of Human Research Oversight (OHRO), and the Research Oversight Board (ROB) of the

Defense Threat Reduction Agency (DTRA), both of which provide DoD compliance oversight to the

CBD SBIR and STTR program office.

NOTE: The offeror is expressly forbidden from beginning the research in any manner prior to these approvals. Furthermore, modifications to approved protocols require review and approval by the OHRO prior to implementation.

Non-compliance with these terms and conditions may result in withholding of funds and/or the termination of the award. The OHRO and DTRA ROB reviews are separate from, and in addition to the responsible Institutional Review Board (IRB) review(s). Further information may be required if the proposal is successful.

CBD – 10

CBD SBIR 25.4 Topic Index

Release 12

CBD254-005 Complex Geometries for Extended Wear Respirators Towards Regenerable Particulate

Matter Protection

CBD254-006 Novel Sampling Tickets for Surface Enhanced Raman Spectroscopy (SERS) of Chemical and Biological (CB) Threat Materials

CBD254-007 Integrated Deployable Microsensors for Chemical Detection

CBD254-008 Far Forward Manufacturing of CBRN Sensors

CBD254-009 OPEN TOPIC – Tactical CB Visualization

CBD254-010 Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics

CBD254-011 OPEN TOPIC – Expeditionary Biologics-on-Demand (BOND)

CBD254-012 Microphysiological systems to Assess Pretreatment Immunogenicity and Efficacy

(MAGPIE)

CBD – 11

CBD254-005 TITLE: Complex Geometries for Extended Wear Respirators Towards Regenerable

Particulate Matter Protection

OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Advanced Materials

OBJECTIVE: Develop a rugged, 3D printable PFAS-free particulate filtration impactor system that readily attaches to a respirator/mask and is suitable for extended wear in military operational environments with high particulate matter levels during aerobic activity.

DESCRIPTION: Warfighters can be deployed in operational environments with high airborne particulate matter (PM) levels; these events lead to a significant risk of developing cardiovascular and pulmonary disease. Adverse health effects, including cardiovascular and pulmonary disease, are well-documented consequences of exposure to high levels of PM with aerodynamic diameters of less than 10 μm (PM10) and especially less than 2.5 μm (PM2.5). In many deployment environments as well as in training facilities (e.g., indoor firing ranges and shoot houses), military personnel are continually exposed to levels of PM that exceed the military exposure guidelines (MEG).1 These levels can be greatly exaggerated by anthropogenic activity when exposed to lead residue, burn pits, or dust storms.

Unfortunately, current particulate filtration technologies are not idealized for extended wear during military operations. A high burden is associated with utilizing current protective gear while participating in high levels of aerobic activity. The primary complaint that limits use of masks and respirators is discomfort caused by breathing resistance. Due to the extreme levels of PM in some deployed settings, there is the recurring issue of clogging, which further increases breathing resistance and wearer burden.

Current filtering equipment is single use, which adds an additional logistics burden when masks/filters need to be continually replaced. Furthermore, many current technologies that provide inhalation protection from particulates utilize HEPA/HESPA media, which can contain PFAS materials. With the environmental and long-term health concerns and regulations facing industries, many manufacturers have announced they are moving away from producing PFAS containing materials – this shift could result in a breakdown in the supply chain of particulate matter protection without the development of suitable alternatives.

The objective of this effort is to develop a rugged, novel particulate impactor system that can readily be manufactured at the point of need and attached to current respirators, such as the M50 respirator, commercial half-masks, P100-style masks, and/or balaclava masks and be regenerated after use. This particulate impactor system should be able to trap aerosols upon inhalation. After use, filter media should be capable of regeneration via the removal of any captured PM, allowing the filter to be used again. Here, regeneration refers to the removal of trapped particles after use such that all channels are cleared, and regeneration may be achieved by a secondary step such as reversed air flow through the media from compressed air. Additionally, the ideal system should be able to allow high flow volumes with minimal breathing resistance and should be suitable for wear during aerobic activity. It must also be resistant to clogging and not rely on PFAS-containing media. Technologies utilizing the complex geometries that are enabled by additive manufacturing offer a promising solution towards this mission space due to complex geometries such as lattice structures offering filtration mechanisms such as impaction.2 Additionally, additive manufacturing of this technology enables this novel particulate-focused filtration solution to be manufactured in a forward deployed environment. Technologies that meet the performance criteria will be considered; however, priority shall be given to innovative or novel designs with minimal size and weight, adaptable to respirator/filter design, able to be manufactured under contested logistics, fully self-contained, able to regenerate after use, and have minimal to no power requirements.

PHASE I: Develop and demonstrate filtration technology at a swatch maturity that significantly reduces

PM10 and PM2.5 levels and is suitable for integration into a wearable device. The technology must be

CBD – 12

tested using polydisperse aerosol particles from 0.1-10 μm at a concentration of 100 mg/m3 for PM10 and PM2.5, respectively. The polydisperse aerosol should be formed from both liquids and solids.

Minimum operating characteristics for the Phase I demonstration is a reduction of solid and oil particulate concentrations by greater than 95%, and a resistance to clogging for 12 hours. Additionally, the demonstration should also include a data package that indicates low breathing resistance at a moderate static flowrate of 85 L/min before and after loading. For a system before exposure to particulates the target pressure drop is less than 5 mmH2O for inhalation and less than 3 mmH2O for exhalation, and the pressure drop after loading should be less than 2x the initial pressure drop value. At the conclusion of Phase I, 3 swatches that are 5.3’’ in diameter (thickness should not exceed 2.5’’) should be delivered to the government POC.

PHASE II: To demonstrate the system’s ability to regenerate, capture efficiency and pressure drop of the filter technology should be tested over 3 filtration regeneration cycles under the testing conditions outlined in Phase I. The capture efficiency should not decrease more than 5% per cycle, and the pressure drop should not increase by 5% per cycle. Additionally, these tests should be repeated using a higher static flow rate of 150 L/min to simulate high aerobic activity. Under these conditions, the target pressure drop is less than 3 mmH2O for inhalation and less than 2 mmH2O for exhalation, and the pressure drop after loading should be less than 2x. Additionally, a reduction of particulate concentrations by greater than 99% and a resistance to clogging for 24 hours should be demonstrated.

The most promising swatch design from these tests should be adapted into a prototype particulate impactor system that is able to be attached to a mask or respirator. Ideally, in the form of a filter module which can interface with a commercially available half-mask respirator. At the conclusion of Phase II, early design and protypes should be developed that demonstrate how the system will integrate into a commercial respirator/mask system, and a minimum of 10 swatches, but preferably up to 25, of similar size to Phase I should be delivered to the government POC.

PHASE III: The overall goal of the project is to develop a NIOSH P100 compliant particulate impactor system that has extreme performance characteristics for low breathing resistance, resistance to clogging, and can be regenerated. Any reduction in exposure of particulates by a mask is dependent upon having a product that fits closely to the face and is correctly donned and worn. Consequently, the fit characteristics of the device that is attached to a commercial mask should be tested using the OSHA quantitative fit testing protocol (1910.134 App A), utilizing test participants that fall within cells 4-7 of the NIOSH-NPPTL bivariate test panel.3 To accommodate the recurring daily use of the device, the prototype should be designed to ensure comfortable fitting with minimal facial abrasions. Additionally, the design must be easily serviceable by the user. As a demonstration of user acceptability, external surveys should be conducted on the overall design, integration, and comfort of the system. Finally, a demonstration for a route to commercialization for scaled production as well as integration into forward deployed efforts should be completed.

PHASE III DUAL USE APPLICATIONS: Potential alternative applications include industrial, agriculture, construction, mining, pharmaceutical, healthcare, international, and other commercial respiratory protection uses.

REFERENCES:

1. https://www.osha.gov/sites/default/files/publications/OSHA3772.pdf

2. Yu, Y.; Zhang, N.; Hoffman, D.; Rastogi, D.; Woodward, I.; Fromen, C. Design and Evaluation of

3D-Printed Lattice Structures as High Flow Rate Aerosol Filters. ACS Appl. Eng. Mater. 2024, 2, 2875−2884. https://doi.org/10.1021/acsaenm.4c00562

3. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.134AppA

KEYWORDS: Respirator, Particulates, Aerosol, Individual Protection, Advanced Manufacturing https://www.osha.gov/sites/default/files/publications/OSHA3772.pdf https://doi.org/10.1021/acsaenm.4c00562

CBD – 13

CBD254-006 TITLE: Novel Sampling Tickets for Surface Enhanced Raman Spectroscopy (SERS) of

Chemical and Biological (CB) Threat Materials

OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Advanced Materials, Quantum Science

OBJECTIVE: This topic seeks disruptive technologies applied to the development of physically semi-porous flexible coupons (e.g. paper or polymer with plasmonic nanoparticles) to sample from a range of smooth and rough or abrasive surfaces found in operational environments using Surface Enhanced

Raman Spectroscopy (SERS). Ideally, these tickets would be designed with multiple SERS substrates

(either mixed or located in specific separate regions of the coupon) to target multiple classes of chemical and biological (CB) hazards (e.g., toxins, fentanyl analogs). Such coupons would greatly expand the capabilities of fielded hand-held Raman spectrometers from bulk detection and identification to detection of trace/residue amounts of hazard and potentially improving the selectivity against impurities co-present in the sample. Coupons would ideally be compatible with any fielded Raman device and with wavelengths of 785nm, 830nm and 1064 nm.

DESCRIPTION: The Department of Defense has fielded several handheld Raman detectors over the past 15 years to support specialized chemical, biological, radiological, and nuclear (CBRN) units across the services and Special Operations forces. These detectors typically contain very large libraries (in the thousands) of solid and liquid chemicals (including toxins, as chemicals of biological origin) that are identifiable with the device. However, these devices typically require a “bulk” amount of liquid or solid sample (grams or milliliter amounts) and have difficulty in identification of chemicals in mixtures of materials. SERS is a technique that offers the potential to greatly enhance the sensitivity and selectivity of current and future handheld Raman detectors. SERS coupons are typically inexpensive with very low size and weight and require no additional power or sample preparation, making them a highly attractive option for soldiers already heavily physically burdened. However, SERS signals can vary significantly between different substrates and even within the same substrate, making it difficult to establish consistent measurements. Factors including substrate fabrication, material homogeneity, and analyte adsorption all contribute to this variability.

This topic seeks approaches to overcoming these challenges with application to the range of threat chemicals that could be encountered on the battlefield in liquid or solid form. These include but are not limited to nerve agents, blister agents, arsenicals, pharmaceutical based agents, and toxins. Proposals should provide an innovative solution to the specified need. They should address a science-based approach to how promising substrates are identified and patterned on a coupon (either as a patterned mixture of substrates, separate spots of different substrates, or other). Consideration of consistency in substrate materials and patterning should be addressed. Please include science-based analysis of predicted selectivity and sensitivity enhancements spanning representative members of several previously noted classes of compounds. Preliminary data is preferred to supplement modeling, simulation and analysis, and surrogate chemicals may be used in place of highly regulated target chemicals.

PHASE I: Awardees should provide a comprehensive approach to how substrates are selected or designed and fabricated for enhanced selectivity and sensitivity over the bulk amount of relatively high purity chemicals required by hand-held Raman detectors and comparison to current commercially available substrates. They should address how the substrates will be patterned on a flexible coupon – both in selection of one or more patterns as well as attaining consistent patterning and reproducibility of the production process. A plan for the demonstration of enhancements in Raman identification of target materials (chemical, biological, toxin, and/or explosives) or reasonable surrogates sampled from various surfaces in various operationally realistic mixtures (e.g. minute amounts of nerve agent surrogate dimethyl methyl phosphonate sampled from military painted metal) must be included.

CBD – 14

PHASE II: In Phase II, the performer shall initially obtain or produce substrates and produce patterned prototype coupons. Their performance should be demonstrated to both dilute chemical targets or surrogates delivered directly to the coupon and those same chemicals in operationally relevant mixtures sampled from a surface to understand the enhancement in sensitivity and selectivity for the latter. At a minimum, substrates should be able to show SERS enhancement for 1 µm solutions of BPE (1,2-bis(4-pyridyl)ethylene) and 1 mM solutions of 4-Nitrophenol. This demonstration should include sufficient replicates at the lower end of detection to provide statistically useful variability data at the 80% confidence level. Enhancements to patterns and/or the patterning process may be required to reduce variability. Upon finalization of the patterning process, a Bayesian limit-of-detection at the 80% confidence level will be required for each selected target chemical mixture. During Phase II the performer shall deliver no less than 50 substrates for independent analysis at DEVCOM Chemical

Biological Center.

PHASE III: Phase III will begin the transition into advanced development for fielding across the services, Special Operations forces, and the National Guard Bureau. Typically, government-developed technology finds its way into non-DoD and commercial entities as commercial-off-the shelf products.

As a very low size, weight, cost and unpowered enhancement to existing field handheld Raman detectors, it is expected to be rapidly fielded as an enhancement to the existing fielded materiel.

PHASE III DUAL USE APPLICATIONS: If successful, this product would greatly enhance screening of cargo and mail for the detection of toxic chemicals at organizations such as the Department of Homeland Security’s Customs and Border Protection and United States Coast Guard, as well as the presence of toxins in food and counterfeit drugs for the Food and Drug Administration. It has great promise to support commercial entities in testing for the presence of toxic substances in foods (e.g.

toxins).

1. X. Tang et al, Trends in Food Science & Technology Volume 152, October 2024 and references therein.

2. Emmons, E. D., Guicheteau, J. A., Fountain III, A. W., Tripathi, A. “Effect of Substituents on

Surface Equilibria of Thiophenols and Isoquinolines on Gold Substrates Studied Using Surface-

Enhanced Raman Spectroscopy”. Phys. Chem. Chem. Phys. 2020, 22, 15953-15965.

3. Guicheteau, J. A., Tripathi, A., Emmons, E. D., Christesen, S. D., Fountain III, A. W. “Reassessing

SERS enhancement factors: using thermodynamics to drive substrate design”. Faraday Discuss.

2017, 205, 547-560.

4. Guicheteau, J. A, Farell, M. E., Christesen, S. D., Fountain III, A. W., Pelligrino, P. M., Emmons, E.

D., Tripathi, A., Wilcox, P., Emge, D. “Surface-enhanced Raman Scattering (SERS) Evaluation

Protocol for Nanometallic Surfaces”. Appl. Spec. 2013, 67, 4, 396-403.

KEYWORDS: SERS, Raman, chemical, toxin, substrate, CBRN, CB https://www.sciencedirect.com/journal/trends-in-food-science-and-technology https://www.sciencedirect.com/journal/trends-in-food-science-and-technology/vol/152/suppl/C

CBD – 15

CBD254-007 TITLE: Integrated Deployable Microsensors for Chemical Detection

OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Microelectronics, Advanced Materials, Integrated Sensing and Cyber

The technology within this topic is restricted under the International Traffic in Arms Regulation (ITAR), 22 CFR Parts 120-130, which controls the export and import of defense-related material and services, including export of sensitive technical data, or the Export Administration Regulation (EAR), 15 CFR

Parts 730-774, which controls dual use items. Offerors must disclose any proposed use of foreign nationals (FNs), their country(ies) of origin, the type of visa or work permit possessed, and the statement of work (SOW) tasks intended for accomplishment by the FN(s) in accordance with the Announcement.

Offerors are advised foreign nationals proposed to perform on this topic may be restricted due to the technical data under US Export Control Laws.

OBJECTIVE: Develop low size, weight, power, and cost (SWaP-C) microsensor for chemical threats that can be easily distributed and networked to support integrated early warning.

DESCRIPTION: Design and fabricate a low SWaP-C microsensor that can be easily distributed across the battlespace would provide integrated early warning of chemical threats. A chemical threat microsensor will be designed to detect chemical weapons agents (nerve and blister classes) and pharmaceutical based agents in vapor and aerosol forms, in near real time. The sensor will maximize use of innovative sensing modalities to provide class-based, presumptive chemical threat detection in less than 10 minutes. The sensor will be readily deployable through multiple means, including unmanned vehicles, projectiles, or hand emplacement to enhance rapid response and decision making. The sensor will collect and feed high density data in near real time to support mission command systems and create a

CBRN common operating picture. The sensor will self-calibrate and continuously operate in a complex operational environment. The final system will employ rapid and networked signal processing algorithms to exchange data with network operators.

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .